In particular, a deeper investigation of the signaling pathways involving α-syn, neuroinflammation, beta-amyloid (Aβ) and p-tau pathology, neurofilaments light chain (NfL), and axonal injury and degeneration may provide unprecedented information on PD pathophysiology and contribute substantially to the biomarker discovery process. This evidence concerns the gene MAPT and Parkinson disease.